awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36661727-87E4A886-571F-4041-AD62-9F1B3829C98B
Q36661727-87E4A886-571F-4041-AD62-9F1B3829C98B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36661727-87E4A886-571F-4041-AD62-9F1B3829C98B
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.
P2860
Q36661727-87E4A886-571F-4041-AD62-9F1B3829C98B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36661727-87E4A886-571F-4041-AD62-9F1B3829C98B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c917281b8bfca4c3222500e1c9b3e4f8aeb48179
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.